Health supervision and anticipatory guidance in adult myotonic dystrophy type 1

Neuromuscular Disorders

Volumn 20, Issue 12, 2010, Pages 847-851

  Gagnon, C ^a,c   Chouinard, M C ^a,d   Laberge, L ^e,f   Veillette, S ^e   Begin P ^a,c,f   Breton, R ^a,f   Jean, S ^a   Brisson, D ^b,f,g   Gaudet, D ^b,f,g   Mathieu, J ^a,b,f,g  

^a Centre de readaptation en deficience physique Jonquiere   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITÉ DE SHERBROOKE   (Canada)

^d UNIVERSITÉ DU QUÉBEC À CHICOUTIMI   (Canada)

^e Ecobes Group   (Canada)

^f Centre hospitalier universitaire de Chicoutimi   (Canada)

^g NONE   (Canada)

Author keywords

All neuromuscular disorders; All rehabilitation; Clinical guidelines; Health management; Medical care; Muscle disease; Myotonic dystrophy; Trinucleotide repeats diseases

Indexed keywords

ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; COGNITIVE DEFECT; DAYTIME SOMNOLENCE; DYSPHAGIA; FATIGUE; GASTROINTESTINAL DISEASE; HEALTH CARE DELIVERY; HEART DISEASE; HUMAN; METABOLIC DISORDER; MUSCLE DISEASE; MYOTONIC DYSTROPHY; PATIENT CARE; PATIENT MONITORING; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; QUALITY OF LIFE; REHABILITATION CARE; RESPIRATORY TRACT DISEASE; SOCIAL ENVIRONMENT; SOCIOECONOMICS; SYSTEMATIC REVIEW; UROGENITAL TRACT DISEASE; VISUAL IMPAIRMENT;

EID: 78649391800     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2010.08.006     Document Type: Article

References (24)

1. Mathieu J., De Braekeleer M., Prévost C. Genealogical reconstruction of myotonic dystrophy in the Saguenay-Lac-Saint-Jean area (Quebec, Canada). Neurology 1990, 40(5):839-842.
2. Harper P. Myotonic dystrophy 2001, WB Saunders, London. 3rd ed.
3. Brook J.D., McCurrach M.E., Harley H.G., Buckler A.J., Church D., Aburatani H., et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member [published erratum appears in Cell 1992;69(2):385]. Cell 1992, 68(4):799-808.
4. Mahadevan M., Tsilfidis C., Sabourin L., Shutler G., Amemiya C., Jansen G., et al. Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene. Science (New York, NY) 1992, 255(5049):1253-1255.
5. Fu Y.H., Pizzuti A., Fenwick R.G., King J., Rajnarayan S., Dunne P.W., et al. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science (New York, NY) 1992, 255(5049):1256-1258.
6. Koch M.C., Grimm T., Harley H.G., Harper P.S. Genetic risks for children of women with myotonic dystrophy. Am J Hum Genet 1991, 48(6):1084-1091.
7. Brisson D., Houde G., St-Pierre J., Vohl M.C., Mathieu J., Gaudet D. The pleiotropic expression of the myotonic dystrophy protein kinase gene illustrates the complex relationships between genetic, biological and clinical covariates of male aging. Aging Male 2002, 5(4):223-232.
8. Hilton-Jones D. Myotonic dystrophy: forgotten aspects of an often neglected condition. Curr Opin Neurol 1997, 10(5):399-401.
9. Myotonic dystrophy: present management, future therapy 2004, Oxford University Press, New York. P. Harper, B. van Engelen, B. Eymard, D. Wilcox (Eds.).
10. Gagnon C., Noreau L., Moxley R.T., Laberge L., Jean S., Richer L., et al. Towards an integrative approach to the management of myotonic dystrophy type 1. J Neurol Neurosurg Psychiatry 2007, 78(8):800-806.
11. Wilson G.N. Preventive medicine for genetic disorders. Am J Med Genet 1999, 89(2):55-57.
12. Battaglia A., Carey J.C. Health supervision and anticipatory guidance of individuals with Wolf-Hirschhorn syndrome. Am J Med Genet 1999, 89(2):111-115.
13. Fougeyrollas P., Cloutier R., Bergeron H., Côté J., St-Michel G. The Quebec classification: disability creation process 1999, International Network on the Disability Creation Process, Lac-St-Charles, Quebec.
14. International Classification of Functioning, Disability and Health: ICF 2001, World Health Organization, World Health Organization, Geneva.
15. Perron M., Veillette S., Mathieu J. La dystrophie myotonique: I. Caractéristiques socio-économiques et résidentielles des malades. Can J Neurol Sci 1989, 16(1):109-113.
16. Laberge L., Veillette S., Mathieu J., Auclair J., Perron M. The correlation of CTG repeat length with material and social deprivation in myotonic dystrophy. Clin Genet 2007, 71(1):59-66.
17. Gagnon C., Mathieu J., Noreau L. Life habits in myotonic dystrophy type 1. J Rehabil Med 2007, 39(7):560-566.
18. Gagnon C., Mathieu J., Jean S., Laberge L., Perron M., Veillette S., et al. Predictors of disrupted social participation in myotonic dystrophy type 1. Arch Phys Med Rehabil 2008, 89(7):1246-1255.
19. Jean S, Richer L, Mathieu J. Intellectual functioning in a large sample of adult and late-onset DM1 patients. 6th International Myotonic Dystrophy Consortium Meeting, September 12-15, Milan, Italy; 2007.
20. Grol R., Wensing M. What drives change? Barriers to and incentives for achieving evidence-based practice. Med J Aust 2004, 180(Suppl.):s57-s60.
21. Knottnerus J.A. Community genetics and community medicine. Fam Pract 2003, 20(5):601-606.
22. Campbell H., Hotchkiss R., Bradshaw N., Porteous M. Integrated care pathways. BMJ 1998, 316(7125):133-137.
23. Wilson I. Case management. Psychosocial interventions for people with schizophrenia 2002, Palgrave, Macmillan, Basingstoke. N. Harris (Ed.).
24. Hudon C., Fortin M., Vanasse A. Cumulative Illness Rating Scale was a reliable and valid index in a family practice context. J Clin Epidemiol 2005, 58(6):603-608.